EVs carrying Hsps, anti-Hsp antibodies, and Hsp-based anticancer vaccines are also examined to provide a reasonably complete matrix of information on the pathogenic roles and potential in anti-BC therapeutics of Hsp27, Hsp60, Hsp70, and Hsp90. Here, HSPA1A is linked to breast cancer.